Ewha Med J.  1982 Mar;5(1):17-23. 10.12771/emj.1982.5.1.17.

The Clinicopathological Study on the Uterine Myoma

Affiliations
  • 1Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University, Seoul, Korea.

Abstract

It is estimated that fully 20% of all women over 35 years of age harbor uterine myoma. This clinicopathological study on the uterine myoma was based upon 138 cases which were operated and diagnosed in the Dept. of Obstetrics and Gynecology, Ewha Womans University Hospital from the beginning of 1972 to the end of 1979. Summaries of the results were as follows: 1. Myoma was 6.1% of the total major gynecological operations. 2. The most frequent age group was 40-49 years(60.1%). There was the most common in case with parity 3 and the mean age of menarche was 16.0 years. 3. Majority of cases were corporeal myoma, 90.6%, whereas cervical myomas were 7.2%. The types of tumor consist of 47.1% of intramural myoma, 22.5% of subserous myoma and 14.5% of submucous myoma. 4. Pain and pressure symptoms were the most common chief complaints(69.5%), whereas abnormal uterine bleeding in 52.2% and palpable mass in 31.9% in orders. 5. Infertility was observed in 21% of all cases(primary infertility; 6.5% and secondary infertility 14.5%). Hemoglobin less than 10.0gm% was seen in 21.1%. 6. Total abdominal hysterectomy was performed in the majority cases(90.6%). There was no mortality due to operation. 7. The most commonly associated condition in myoma was adenomyosis(19.5%) and the most fequent secondary change was hyaline degeneration.(6.5%) 8. Postoperative morbidity was found in 12.3% of all cases and wound infection(4.3%) was the most common morbidity.


MeSH Terms

Female
Gynecology
Humans
Hyalin
Hysterectomy
Infertility
Leiomyoma*
Menarche
Mortality
Myoma
Obstetrics
Parity
Uterine Hemorrhage
Wounds and Injuries
Full Text Links
  • EMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr